Gold nanoparticles enhances radiosensitivity in glioma cells by inhibiting TRAF6/NF-κB induced CCL2 expression
Hao Wang,
Qian Xu,
Xianning Dong,
Zhiling Guan,
Ziyu Wang,
Yuanyuan Hao,
Ruichun Lu,
Ling Chen
Affiliations
Hao Wang
Department of Oncology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266012, China
Qian Xu
Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266012, China
Xianning Dong
Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266003, China
Zhiling Guan
Department of Surgery, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266012, China
Ziyu Wang
Department of Oncology, People's Hospital of RiZhao, Rizhao, China, postal codes 276827
Yuanyuan Hao
Department of Urology, The First Hospital of Jilin University, Changchun, China, postal codes 130061
Ruichun Lu
Department of Neurology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266012, China; Corresponding author.
Ling Chen
Department of Oncology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266012, China; Corresponding author. Department of Oncology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China.
Gliomas are inherently difficult to treat by radiotherapy because glioma cells become radioresistant over time. However, combining radiotherapy with a radiosensitizer could be an effective strategy to mitigate the radioresistance of glioma cells. Gold nanoparticles (AuNPs) have emerged as a promising nanomaterial for cancer therapy, but little is known about whether AuNPs and X-ray radiation have cytotoxic synergistic effects against tumors. In this study, we found that the combination of AuNPs and X-ray irradiation significantly reduced the viabilities, as well as the migration and invasion, of glioma cells. Mechanistically, we observed that the AuNPs inhibited radiation-induced CCL2 expression by inhibiting the TRAF6/NF-κB pathway, which likely manifested the synergistic therapeutic effect between the AuNPs and X-ray radiation. The AuNPs also re-sensitized radioresistant glioma cells by inhibiting CCL2 expression. These results were also observed in another tumor cell line with a different molecular pattern, indicating that the underlying mechanism may be ubiquitous through cancer cells. Lastly, using the glioma mouse model, we observed that AuNPs significantly reduced tumor growth in the presence of X-ray radiation compared to radiotherapy alone.